Novel fibros drug test model

Datum: 31.8.2015

Summary:
A university spin-off SME in northern Sweden offers a new pre-clinical model for testing new anti-fibrotic and anti-inflammatory drugs. The new model shortens and simplifies the tests, lowering the cost and performs considerably better than the ones existing today. The SME is looking for partners that develop anti-fibrotic drugs or anti-inflammatory drugs, enabling them to do the testing more efficiently. The SME offers licensing of the entire concept and/or delivering test services.
Reference:	TOSE20150427001
Country:	Sweden
Submitted:	Apr 27 2015
Updated:	Jul 10 2015
	View Partnering Opportunity

KEYWORDS
Market:	Cellular and Molecular Biology, Genetic Engineering , Molecular design , Other Genetic Engineering
Technology:	Clinical Research, Trials, Genetic Engineering
NACE:	Research and experimental development on biotechnology